| Bio Pharma |
 |
 |
 |
|
Bio-Pharma is a new area of work at 1Ricci. We work on important proposals with consequences for national security regularly, but these Biologic Pharmaceuticals have important ramifications for public safety in the event of a terrorist attack. BARDA (Biomedical Advanced Research and Development Authority) is charged with finding and supporting development of agents to protect the US population at large from attack with contaminants and agents like Anthrax, developing medical countermeasures and stockpiling medicines for an emergency. Here's the description from the BARDA home page: The Biomedical Advanced Research and Development Authority (BARDA), within the Office of the Assistant Secretary for Preparedness and Response in the U.S. Department of Health and Human Services, provides an integrated, systematic approach to the development and purchase of the necessary vaccines, drugs, therapies, and diagnostic tools for public health medical emergencies. BARDA manages Project BioShield, which includes the procurement and advanced development of medical countermeasures for chemical, biological, radiological, and nuclear agents, as well as the advanced development and procurement of medical countermeasures for pandemic influenza and other emerging infectious diseases that fall outside the auspices of Project BioShield. In addition, BARDA manages the Public Health Emergency Medical Countermeasures Enterprise (PHEMCE). TMTI (Transformational Medical Technologies Intiative) is charged with finding and supporting development of agents to protect military personnel from biological weapons. They are a DoD (Department of Defense) agency. Here's the description from the TMTI homepage: Transformational Medical Technologies Intiative (TMTI) was pioneered by The Department of Defense (DoD) in 2006 to better prepare and protect the warfighter and the nation from emerging, genetically engineered, and unknown biothreat agents. DTRA (Defense Threat Reduction Agency) is a DoD agency focused on WMD (Weapons of Mass Destruction) and supports developments to counter WMDs. Here's the description from the DTRA website (about us): DTRA is the U.S. Department of Defense’s official Combat Support Agency for countering weapons of mass destruction. Our people are Subject Matter Experts on WMD, and we address the entire spectrum of chemical, biological, radiological, nuclear and high yield explosive threats. DTRA’s programs include basic science research and development, operational support to U.S. warfighters on the front line, and an in-house WMD think tank that aims to anticipate and mitigate future threats long before they have a chance to harm the United States and our allies. SCC-WMD, the U.S. Strategic Command Center for Combating Weapons of Mass Destruction, synchronizes Combating Weapons of Mass Destruction efforts across our military’s geographic commands and leverages the people, programs and interagency relationships of DTRA at a strategic level. We work with the military services, other elements of the United States government, and countries across the planet on counterproliferation, nonproliferation and WMD reduction issues with one goal in mind: Making the World Safer. Vaccines for a variety of disease have the attention of agencies responsible for responding to and preventing death from bioterrorist attack. Malaria, mustard gas, anthrax, influenza, nuclear contamination, smallpox, botulism and radioactive contamination are all of interest for these agencies. If you found this page, you may be interested in our services to support your proposal to these or other agencies. If so, please contact us by clicking here. |
Ricci Legacy
The Ricci family has been consulting and supporting success for hundreds of years.